156 related articles for article (PubMed ID: 9784926)
1. Endothelium-smooth muscle interaction in cardiac transplantation.
Skarsgard PL; McManus BM; van Breemen C; Laher I
Clin Exp Pharmacol Physiol; 1998 Oct; 25(10):836-40. PubMed ID: 9784926
[TBL] [Abstract][Full Text] [Related]
2. Profound inhibition of myogenic tone in rat cardiac allografts is due to eNOS- and iNOS-based nitric oxide and an intrinsic defect in vascular smooth muscle contraction.
Skarsgard PL; Wang X; McDonald P; Lui AH; Lam EK; McManus BM; van Breemen C; Laher I
Circulation; 2000 Mar; 101(11):1303-10. PubMed ID: 10725291
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine treatment preserves coronary resistance artery function in rat cardiac allografts.
Moien-Afshari F; Choy JC; McManus BM; Laher I
J Heart Lung Transplant; 2004 Feb; 23(2):193-203. PubMed ID: 14761767
[TBL] [Abstract][Full Text] [Related]
4. Expression of endomyocardial nitric oxide synthase and coronary endothelial function in human cardiac allografts.
Wildhirt SM; Weis M; Schulze C; Conrad N; Pehlivanli S; Rieder G; Enders G; von Scheidt W; Reichart B
Circulation; 2001 Sep; 104(12 Suppl 1):I336-43. PubMed ID: 11568079
[TBL] [Abstract][Full Text] [Related]
5. Inducible nitric oxide synthase expression in smooth muscle cells and macrophages of human transplant coronary artery disease.
Ravalli S; Albala A; Ming M; Szabolcs M; Barbone A; Michler RE; Cannon PJ
Circulation; 1998 Jun; 97(23):2338-45. PubMed ID: 9639378
[TBL] [Abstract][Full Text] [Related]
6. Myocardial contractile effects of L-arginine in the human allograft.
Paulus WJ; Kästner S; Vanderheyden M; Shah AM; Drexler H
J Am Coll Cardiol; 1997 May; 29(6):1332-8. PubMed ID: 9137232
[TBL] [Abstract][Full Text] [Related]
7. Coronary flow reserve and nitric oxide synthases after cardiac transplantation in humans.
Wildhirt SM; Weis M; Schulze C; Conrad N; Pehlivanli S; Rieder G; Enders G; von Scheidt W; Reichart B
Eur J Cardiothorac Surg; 2001 Jun; 19(6):840-7. PubMed ID: 11404140
[TBL] [Abstract][Full Text] [Related]
8. An association between microvascular endothelial dysfunction, transcardiac nitric oxide production and pro-inflammatory cytokines after heart transplantation in humans.
Wildhirt SM; Weis M; Schulze C; Conrad N; Rieder G; Enders G; Hoepp C; von Scheidt W; Reichart B
Transpl Int; 2000; 13 Suppl 1():S228-34. PubMed ID: 11112001
[TBL] [Abstract][Full Text] [Related]
9. Pathogenetic mechanisms of cardiac allograft vasculopathy--impact of nitric oxide.
Koglin J
Z Kardiol; 2000; 89 Suppl 9():IX/24-7. PubMed ID: 11151787
[TBL] [Abstract][Full Text] [Related]
10. Regulation of coronary blood flow during exercise.
Duncker DJ; Bache RJ
Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of inducible nitric oxide synthase prevents myocardial and systemic vascular barrier dysfunction during early cardiac allograft rejection.
Worrall NK; Chang K; Suau GM; Allison WS; Misko TP; Sullivan PM; Tilton RG; Williamson JR; Ferguson TB
Circ Res; 1996 May; 78(5):769-79. PubMed ID: 8620596
[TBL] [Abstract][Full Text] [Related]
12. Temporal changes in myocardial endothelial nitric oxide synthase expression following human heart transplantation.
Vejlstrup NG; Andersen CB; Boesgaard S; Mortensen SA; Aldershvile J
J Heart Lung Transplant; 2002 Feb; 21(2):211-6. PubMed ID: 11834349
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of inducible nitric oxide synthase and superoxide production reduces matrix metalloproteinase-9 activity and restores coronary vasomotor function in rat cardiac allografts.
Egi K; Conrad NE; Kwan J; Schulze C; Schulz R; Wildhirt SM
Eur J Cardiothorac Surg; 2004 Aug; 26(2):262-9. PubMed ID: 15296881
[TBL] [Abstract][Full Text] [Related]
14. Discordant epicardial and microvascular endothelial responses in heart transplant recipients early after transplantation.
Hollenberg SM; Tamburro P; Klein LW; Burns D; Easington C; Costanzo MR; Parrillo JE; Johnson MR
J Heart Lung Transplant; 1998 May; 17(5):487-94. PubMed ID: 9628567
[TBL] [Abstract][Full Text] [Related]
15. Upregulation and modulation of inducible nitric oxide synthase in rat cardiac allografts with chronic rejection and transplant arteriosclerosis.
Russell ME; Wallace AF; Wyner LR; Newell JB; Karnovsky MJ
Circulation; 1995 Aug; 92(3):457-64. PubMed ID: 7543380
[TBL] [Abstract][Full Text] [Related]
16. Coronary vasomotor dysfunction in the cardiac allograft: impact of different immunosuppressive regimens.
Weis M; Wildhirt SM; Schulze C; Pehlivanli S; Rieder G; Wolf WP; Wilbert-Lampen U; Meiser BM; Enders G; von Scheidt W
J Cardiovasc Pharmacol; 2000 Dec; 36(6):776-84. PubMed ID: 11117379
[TBL] [Abstract][Full Text] [Related]
17. Cardiac allograft vasculopathy and dysregulation of the NO synthase pathway.
Weis M; Cooke JP
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):567-75. PubMed ID: 12649081
[TBL] [Abstract][Full Text] [Related]
18. Time course of coronary endothelial dysfunction in acute untreated rejection after heterotopic heart transplantation.
Perrault LP; Bidouard JP; Janiak P; Villeneuve N; Bruneval P; Vilaine JP; Vanhoutte PM
J Heart Lung Transplant; 1997 Jun; 16(6):643-57. PubMed ID: 9229295
[TBL] [Abstract][Full Text] [Related]
19. Time course of endothelial function in epicardial conduit coronary arteries and in the microcirculation in the long-term follow-up after cardiac transplantation.
Hartmann A; Mazzilli N; Weis M; Olbrich HG; Burger W; Satter P
Int J Cardiol; 1996 Feb; 53(2):127-36. PubMed ID: 8682598
[TBL] [Abstract][Full Text] [Related]
20. Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle.
Lewis NP; Tsao PS; Rickenbacher PR; Xue C; Johns RA; Haywood GA; von der Leyen H; Trindade PT; Cooke JP; Hunt SA; Billingham ME; Valantine HA; Fowler MB
Circulation; 1996 Feb; 93(4):720-9. PubMed ID: 8641001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
